← Back to Search

Virtual Reality Technology

VR Gaming Therapy for Stroke Rehabilitation

N/A
Waitlist Available
Led By Seema S Aggarwal, PhD, APRN, AGNP-C
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, after each session (3 times a week for 4 weeks about 12 total sessions)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a virtual reality game can help stroke survivors with arm and cognitive impairments, and the impact it has on caregivers.

Who is the study for?
This trial is for chronic stroke survivors who had a stroke between 6 months to 2 years ago, can communicate in English, and are able to consent. They should have mild-moderate cognitive and arm impairments but cannot join if they have severe cognitive issues, certain neurological deficits like aphasia or hemiopsia, motion sickness/vertigo/dizziness/seizures, claustrophobia, blindness/deafness or can't hold the controller.
What is being tested?
The study tests how feasible and acceptable it is for stroke survivors with arm and cognitive impairments to use Oculus VR technology for rehabilitation. It measures changes in their abilities using standard tests and includes interviews with caregivers about their involvement in the rehab process.
What are the potential side effects?
Potential side effects of using Oculus VR may include discomfort such as dizziness or nausea (especially if prone to motion sickness), eye strain from prolonged screen exposure, headaches due to virtual reality immersion or fatigue from physical activity during gaming.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, after each session (3 times a week for 4 weeks about 12 total sessions)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, after each session (3 times a week for 4 weeks about 12 total sessions) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability (ease of use) as assessed by the score on the Simulator Sickness Questionnaire (SSQ) questionnaire
Change in arm impairment as assessed by Fugl Meyer - Upper Extremity assessment
Change in burden of caregivers in supporting the stroke survivor as assessed by the Burden Scale for Family Caregivers - short version
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Oculus VRExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oculus VR
2023
N/A
~40

Find a Location

Who is running the clinical trial?

IoT and Aging in Place Joint Seed GrantUNKNOWN
The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
348,035 Total Patients Enrolled
45 Trials studying Stroke
9,497 Patients Enrolled for Stroke
Seema S Aggarwal, PhD, APRN, AGNP-CPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~12 spots leftby Dec 2025